2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure-activity relationship (SAR) studies-Reference-Cited by-同舟云学术

2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure-activity relationship (SAR) studies

Published:2017-01 Issue: Volume:126 Page:823-843
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Mohamed Tarek,Rao Praveen P.N.^ORCID

Funder

Ontario Mental Health Foundation

NSERC-Discovery

Canada Foundation for Innovation

Ontario Research Fund

Early Researcher Award, Ministry of Research and Innovation

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference56 articles.

1. Epidemiological and economic burden of Alzheimer's disease: a systematic literature data across Europe and United States of America;Takizawa;J. Alzheimers Dis.,2015

2. Therapeutic agents for Alzheimer's disease;Suh;Curr. Med. Chem.,2005

3. Cholinesterase inhibitors for Alzheimer's disease;Birks;Cochrane Database Syst. Rev.,2006

4. Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade;Takada-Takatori;Neuropharmacology,2006

5. An overview on natural cholinesterase inhibitors-a multitargeted drug class-and their mass production;Orhan;Mini Rev. Med. Chem.,2011

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and biological evaluation of sulfonamide derivatives containing imidazole moiety as ALK5 inhibitors;Molecular Diversity;2024-08-30

2. Synthesis, biological evaluation, molecular docking, and MD simulation of novel 2,4-disubstituted quinazoline derivatives as selective butyrylcholinesterase inhibitors and antioxidant agents;Scientific Reports;2024-07-06

3. A literature review on pharmacological aspects, docking studies, and synthetic approaches of quinazoline and quinazolinone derivatives;Archiv der Pharmazie;2024-05-22

4. Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment;European Journal of Medicinal Chemistry;2024-05

5. Quinazolines annelated at the N(3)–C(4) bond: Synthesis and biological activity;European Journal of Medicinal Chemistry;2024-05